pqq cofactor has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
Excerpt | Relevance | Reference |
---|---|---|
"Nonalcoholic fatty liver disease (NAFLD) is widespread in adults and children." | 1.46 | Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. ( Alfonso-Garcia, A; de la Houssaye, BA; DeFelice, BC; Fiehn, O; Florey, G; Friedman, JE; Heerwagen, MJ; Janssen, RC; Jonscher, KR; Jonscher, RL; Levi, M; Luo, Y; Potma, EO; Stewart, MS; Wang, XX; Wiitala, E, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Mandala, A | 1 |
Dobrinskikh, E | 1 |
Janssen, RC | 2 |
Fiehn, O | 2 |
D'Alessandro, A | 1 |
Friedman, JE | 2 |
Jonscher, KR | 2 |
Stewart, MS | 1 |
Alfonso-Garcia, A | 1 |
DeFelice, BC | 1 |
Wang, XX | 1 |
Luo, Y | 1 |
Levi, M | 1 |
Heerwagen, MJ | 1 |
de la Houssaye, BA | 1 |
Wiitala, E | 1 |
Florey, G | 1 |
Jonscher, RL | 1 |
Potma, EO | 1 |
2 other studies available for pqq cofactor and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Maternal Pyrroloquinoline Quinone Supplementation Improves Offspring Liver Bioactive Lipid Profiles throughout the Lifespan and Protects against the Development of Adult NAFLD.
Topics: Adult; Animals; Child; Diet, High-Fat; Dietary Supplements; Fatty Acids, Omega-3; Female; Humans; Li | 2022 |
Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice.
Topics: Animals; Antioxidants; Ceramides; Cyclooxygenase 2; Diet, High-Fat; Dietary Supplements; Female; Int | 2017 |